Glossary

Business & Finance Glossary: B

31 terms starting with B, from a glossary of 638 definitions covering intangible assets, valuations, and key financial concepts.

Backlog Analysis

The valuation of a company's existing order book or contracted but undelivered revenue at the measurement date. Backlog is recognised as a contract-based intangible asset under IFRS 3 and ASC 805 when it arises from contractual or legal rights. The income approach is most commonly used, discounting the expected profit from backlog fulfilment over the estimated delivery period, with adjustments for attrition risk and contributory asset charges.

Backlog Intangible

An identifiable intangible asset representing the value of unfulfilled orders or contracts at the date of a business combination. Backlog intangibles are recognised separately under purchase price allocation and are amortised as the underlying orders are fulfilled.

Balanced Scorecard

A strategic management framework developed by Robert Kaplan and David Norton that translates an organisation's vision and strategy into a coherent set of performance measures across four perspectives: financial, customer, internal business processes, and learning and growth. The balanced scorecard is particularly relevant to intangible asset management because three of its four perspectives — customer, process, and learning — directly measure intangible value drivers. By requiring organisations to track metrics beyond financial performance, the framework makes visible the contribution of knowledge capital, customer relationships, process efficiency, and innovation capability to long-term value creation. For SMEs seeking to understand and grow their intangible asset base, the balanced scorecard provides a structured approach to identifying, measuring, and managing the non-financial drivers that account for the majority of modern enterprise value.

Bargain Purchase

A business combination in which the fair value of the identifiable net assets acquired exceeds the consideration transferred, resulting in a gain rather than goodwill. Under IFRS 3 and ASC 805, the acquirer must reassess whether all assets and liabilities have been correctly identified and measured before recognising a bargain purchase gain in profit or loss. Bargain purchases may arise in distressed sales, forced divestitures, or where sellers prioritise speed over price.

Basel III

An international regulatory framework developed by the Basel Committee on Banking Supervision that sets minimum capital requirements, leverage ratios, and liquidity standards for banks. Basel III was introduced in response to the 2008 financial crisis and requires banks to hold higher-quality capital (primarily Common Equity Tier 1) against risk-weighted assets, including operational risk and market risk.

Basis of Value

Basis of value is the fundamental assumption about the transaction and parties that a valuation measures - in effect, the precise question the valuer is answering. Under the International Valuation Standards the basis of value is a formal statement (renumbered to IVS 102 in the 2025 edition, previously IVS 104) that must be selected and disclosed before any figure is produced, because the same intangible asset can carry very different values depending on which basis is chosen. Market value, fair value and investment value are distinct bases, and each answers a different question: what a willing buyer would pay in an arm's-length exchange, what the asset is worth to a specific party, or what accounting standards require. For IP-backed lending the choice is decisive. A going-concern basis reflecting the asset's value inside a thriving business is unsuitable for collateral, because a lender realises security precisely when the business is failing. Consequently a credit-standard valuation pairs an appropriate basis of value with a conservative premise - typically orderly-liquidation - so the resulting figure represents what the IP would fetch on a default, not on a good day. This distinction protects both sides. A UK founder seeking to borrow against a patent portfolio benefits from understanding early that the basis of value driving the facility limit is deliberately cautious, avoiding disappointment when the appraised collateral figure sits below the marketing valuation. For the accountant or broker packaging the deal, stating the basis of value explicitly - and confirming it aligns with what the lender's credit team expects - is a prerequisite for a report that will actually support a facility. IVS 210 governs the intangible-asset methods applied once the basis is fixed, but the basis is chosen first.

Benchmarking

The practice of comparing a company's performance metrics, processes, or practices against industry leaders or best-in-class peers. Benchmarking against productivity and intangible asset data helps firms identify gaps and prioritise investment. In intangible asset management, benchmarking enables organisations to compare their investment in and returns from intangible assets — such as R&D, brand development, and workforce training — against industry peers and best-practice standards.

Beneficial Ownership Register

A public or restricted-access registry identifying the natural persons who ultimately own or control legal entities such as companies, trusts, and partnerships. In the UK, the People with Significant Control (PSC) register is maintained at Companies House, while the EU's Anti-Money Laundering Directives require member states to maintain central beneficial ownership registers. These registers support transparency and anti-money laundering efforts.

Beta Adjustment

The process of modifying an observed equity beta to better reflect the risk characteristics of the subject company being valued. Common adjustments include unlevering betas from comparable public companies to remove the effect of different capital structures, relevering to the subject company's target capital structure, and applying the Blume or Vasicek adjustment to account for beta's tendency to regress toward 1.0 over time.

Biosciences

The application of biological sciences to develop products, processes, and services across sectors including pharmaceuticals, biotechnology, medical devices, agricultural technology, and environmental science. Biosciences companies are among the most intangible-asset-intensive businesses in the global economy, with value concentrated in patents, regulatory approvals, clinical trial data, proprietary compounds, and specialised human capital. The valuation of bioscience intangible assets requires specialist knowledge of drug development pipelines, probability-weighted expected returns, patent cliff analysis, and regulatory pathway assessment. In purchase price allocations following bioscience acquisitions, in-process research and development (IPR&D) often represents the single largest identified intangible asset, valued using the multi-period excess earnings method (MPEEM) with risk adjustments reflecting clinical and regulatory uncertainty.

Biosimilar

A biological medicine that is highly similar to an already approved reference biological product, with no clinically meaningful differences in safety, purity, or potency. Unlike generic small-molecule drugs, biosimilars cannot be exact copies due to the complexity of biological manufacturing processes and require their own clinical trials to demonstrate similarity. The biosimilar approval pathway (under the EU's 2004 framework and the US Biologics Price Competition and Innovation Act of 2009) is more rigorous and costly than generic drug approval, resulting in more modest price discounts (typically 15-35%) compared to small-molecule generics.

Blanket Lien

A security interest that gives a lender a claim against all of a borrower's assets, both current and future, rather than specific identified collateral. Blanket liens are commonly used in small business lending and working capital facilities where itemising individual assets would be impractical. While providing broad coverage, blanket liens rank according to the priority rules of the applicable jurisdiction (UCC in the US, PPSA in Canada, Companies Act in the UK).

Blockbuster Drug

A pharmaceutical product that generates annual revenue exceeding $1 billion, representing a transformational commercial success for its manufacturer. Blockbuster drugs — such as statins, biologics for autoimmune diseases, and oncology treatments — drive the majority of pharmaceutical industry profits and are among the most valuable intangible assets in existence. The blockbuster model depends on patent exclusivity periods, after which generic competition typically erodes revenue by 80-90% within two years of patent expiry.

Blockchain Assets

Digital intangible assets recorded and verified on a distributed ledger, including cryptocurrencies, tokenised securities, non-fungible tokens, and smart contracts. The valuation and accounting treatment of blockchain assets remain an evolving area, with significant implications for enterprise balance sheets.

Board of Directors

A group of individuals elected by shareholders to oversee company management, set strategic direction, and protect shareholder interests. Investor-backed companies typically include board seats for lead investors alongside founder and independent directors. In intangible-rich businesses, effective board oversight extends to the governance of intellectual property strategy, brand management, and talent development — all of which are critical drivers of enterprise value.

Bolt-On Acquisition

A relatively small acquisition made by a private equity portfolio company to complement and enhance its existing operations, typically adding new products, customers, geographies, or capabilities. Bolt-on acquisitions are a core component of buy-and-build strategies and are usually integrated into the platform company rather than operated independently. They are typically valued at lower multiples than the platform company, creating multiple arbitrage and value accretion for the PE fund.

Book Value

Book value is the net asset value of a company as recorded on its balance sheet — total assets minus total liabilities. The formula is simple: Book Value = Total Assets − Total Liabilities. For intangible-rich businesses, book value typically understates economic value by a wide margin because most internally generated intangibles (brands, customer relationships, R&D, organisational capital) are expensed rather than capitalised under IAS 38 and ASC 350. **Worked example.** A SaaS company has £15m total assets on the balance sheet (£5m cash, £8m receivables, £2m equipment) and £8m total liabilities. Book value is £7m. The same business generates £20m ARR with 90% net revenue retention, holds £40m of customer-contract intangibles built over six years of selling, and runs on a proprietary technology platform that took £12m of cumulative R&D to build. None of those intangibles appear on the balance sheet because they were generated internally. The market valuation is £160m — 23× book value. The gap is the intangible asset base that book value doesn't see. **Why the gap matters.** Lenders that anchor on book value underwrite to the wrong number, which is why IP-backed lending programmes (NatWest, HSBC, RBS) increasingly underwrite to intangibles. PE buyers running purchase price allocation under IFRS 3 / ASC 805 turn the gap into goodwill and identifiable intangibles — but only at the point of acquisition. Equity investors price the gap explicitly through valuation multiples that exceed book value by a factor that grows with the intangible-intensity of the sector (typically 1-3× for industrial businesses, 5-15× for SaaS, 20×+ for platform businesses). **Book value vs market value vs intrinsic value.** Market value is what an arm's-length buyer would pay today; intrinsic value is what the discounted cash-flow model produces from the asset's expected economic benefit. Book value is the most conservative of the three because it reflects only what the accounting framework permits onto the balance sheet. Across the S&P 500, the price-to-book ratio has averaged over 3× for two decades — a structural signal that the accounting framework systematically understates economic value in the modern economy. **Practical use.** Founders preparing for a Series A or exit should maintain a separate intangible asset register alongside their statutory accounts. Tracking quarterly investment in brand, customer acquisition, R&D, technology, and organisational capital — even when those costs are expensed — produces the evidence base that supports a valuation conversation with investors, lenders, or acquirers. Book value is a starting point, not an answer.

Borrowing Base

The borrowing base is the amount a lender will make available against a borrower's collateral, calculated as eligible collateral multiplied by its advance rate, less ineligibles and reserves. It is the central mechanic of asset-based lending: rather than fixing a loan amount up front, the facility flexes with the value of the underlying assets, so availability rises and falls as receivables, inventory and other collateral change. The formula is straightforward in principle. Each collateral class is valued, an advance rate is applied (indicatively receivables at 70 to 90 per cent, inventory at around 40 to 65 per cent of cost or up to 80 to 90 per cent of net orderly liquidation value, plant and equipment at roughly 50 to 80 per cent of orderly-liquidation value), and then collateral ineligibles and any lender reserves are subtracted to give availability. In mainstream ABL, IP is usually a marginal top-up valued case by case rather than a core component. For IP-led facilities, however, the intangible drives the base, and its contribution reflects the blended view of separability, saleability and legal strength applied to an orderly-disposal value. A UK example: a growth-stage business might combine a receivables and inventory line under an ABL facility with an IP element, where the IP is appraised by an independent valuer and revalued periodically, mirroring the annual revaluation used on facilities such as NatWest's High Growth IP Loan. The borrowing base matters because it keeps lending tethered to realistic recovery: it protects the lender against over-advancing and gives the borrower a transparent, defensible ceiling on what can be drawn. Field examinations and collateral audits test the reported figures, and any charge over the collateral must be registered at Companies House within 21 days under section 859A of the Companies Act 2006 to remain valid in an insolvency.

Borrowing Base Certificate

A borrowing base certificate is the periodic statement a borrower submits to its lender reporting the current value of eligible collateral, from which available borrowing capacity is calculated. It is the operational document that keeps an asset-based facility honest between formal reviews: the borrower lists receivables, inventory and any other qualifying collateral, applies the agreed advance rates, deducts ineligibles and reserves, and arrives at the availability figure the lender relies on to permit further drawings. Certificates are typically produced monthly, and more frequently where collateral turns over quickly, so both sides can see availability move in near real time. The certificate is only as good as the figures behind it, which is why lenders reconcile it against ageings and management accounts, and periodically send an examiner to conduct a field examination or collateral audit that tests the reported numbers and estimates liquidation value independently. For IP-backed elements, the intangible is not re-measured every cycle in the way receivables are; instead it is appraised by an independent valuer and revalued at set intervals, commonly annually, with that value feeding the base between revaluations. A UK example: a manufacturer drawing on a receivables and inventory facility with an IP top-up would file a monthly borrowing base certificate, and the lender would compare the declared eligible receivables against the aged debtor report before releasing funds. The certificate matters because it enforces discipline and prevents an overadvance, where drawings exceed what the collateral properly supports. For the borrower it is a live view of covenant headroom and liquidity; for the lender it is the audit trail that ties every advance back to verified, eligible collateral and keeps the facility within its agreed risk envelope.

Brand Equity

The commercial value derived from consumer perception of a brand name. Brand equity is one of the most significant intangible assets for consumer-facing businesses and influences pricing power, customer loyalty, and market share. Brand equity is frequently valued using the Relief from Royalty method, estimating the royalty rate a business would pay to license the brand from an independent third party.

Break-Even Point

The level of revenue at which total costs equal total income, resulting in neither profit nor loss. For growth businesses, understanding break-even informs decisions about pricing, unit economics, and the capital required to reach profitability. In intangible-intensive businesses, the break-even point may be reached later than in asset-light models because significant upfront investment in R&D, brand development, and customer acquisition is required before revenue scales.

Bridge Financing

Short-term funding used to bridge the gap between two financing rounds or before an anticipated liquidity event. Bridge loans or convertible notes are common structures, often provided by existing investors to sustain operations until the next milestone. Bridge financing is frequently used to fund intangible asset development milestones — such as completing a technology build, securing regulatory approvals, or achieving key customer wins — that are expected to unlock a significant increase in enterprise valuation.

Bridge Loan

A short-term financing facility designed to provide temporary capital to a company or fund until permanent financing or the next funding round is secured. In the startup context, bridge loans often carry convertible terms that allow the lender to convert the outstanding balance into equity at a discount to the next round's price, compensating for the higher risk of interim financing.

Burn Rate

The rate at which a company spends cash in excess of its income, typically expressed as a monthly figure. Burn rate is a critical metric for startups and growth-stage companies, directly determining how long the business can operate before requiring additional capital (runway).

Business Asset Disposal Relief

Business Asset Disposal Relief (BADR), formerly Entrepreneurs' Relief, is a UK capital gains tax relief that reduces the rate of CGT on qualifying gains when an individual sells all or part of a trading business. It applies a reduced CGT rate on gains up to a lifetime limit, provided conditions on ownership period, shareholding and officer or employee status are met in the period before disposal. Because the qualifying conditions look back over a defined period and depend on how the sale is structured — a share sale versus an asset sale, and how any holding company sits above the trading company — BADR is a reason to plan an exit well ahead rather than at the point of sale. The rate, lifetime limit and conditions are set by HMRC and change from time to time, so an owner should confirm the current rules with a tax adviser. BADR applies only in the UK; other jurisdictions have their own exit reliefs.

Business Model

The framework through which an organisation creates, delivers, and captures value. A business model defines the logic of how a company generates revenue, serves customers, and sustains competitive advantage. In the context of intangible assets, the business model itself can be a significant source of value — particularly when it creates network effects, generates recurring revenue, or builds switching costs that protect the company's market position. Platform business models, subscription models, and freemium models are especially effective at building intangible value because they compound customer relationships, data assets, and ecosystem effects over time. When valuing a business for acquisition or investment, understanding the business model is essential to identifying which intangible assets drive value and how sustainable that value creation is likely to be.

Business Model Innovation

The process of creating, refining, or transforming the fundamental way an organisation creates and captures value. Unlike product or process innovation, business model innovation changes the underlying logic of value creation — potentially disrupting entire industries. Business model innovation is a high-value intangible activity because it can unlock new revenue streams, create new forms of competitive advantage, and redefine customer relationships. Examples include the shift from product sales to subscription models, the creation of two-sided marketplace platforms, and the unbundling of traditional service offerings into modular, technology-enabled solutions. From a valuation perspective, companies that successfully innovate their business model often command significant premiums, as the new model may generate superior economics through better unit economics, stronger network effects, or more defensible market positions.

Business Process

A structured set of activities or tasks that produce a specific output for a particular customer or market. Business processes encompass everything from operational workflows such as order fulfilment and customer onboarding to strategic processes such as product development and strategic planning. Well-designed business processes are valuable intangible assets because they encode organisational knowledge, ensure consistency, enable scalability, and reduce dependence on individual employees. In the context of acquisitions, proprietary business processes can be identified as separately valuable intangible assets — particularly when they deliver measurable efficiency advantages, are documented and repeatable, and would be costly for a competitor to replicate. Process optimisation is also a key driver of productivity growth, as improvements in how work is organised and executed directly increase output per unit of input.

Business Process Modelling

The analytical practice of representing an organisation's workflows, processes, and operations in a structured visual or formal notation to understand, analyse, and improve them. Common modelling techniques include Business Process Model and Notation (BPMN), flowcharts, value stream mapping, and simulation models. Business process modelling is a foundational activity for organisations seeking to optimise their intangible asset base, as it makes tacit operational knowledge explicit and identifies opportunities for automation, elimination of waste, and efficiency improvement. The resulting process models themselves become valuable intangible assets — documented organisational knowledge that can be used for training, compliance, quality management, and as the basis for digital transformation initiatives. For businesses preparing for sale or investment, well-documented process models demonstrate operational maturity and reduce acquirer risk.

Buy-and-Build Strategy

A private equity value creation approach in which a fund acquires a platform company and subsequently makes multiple add-on acquisitions to accelerate growth, expand market share, and create a business of greater scale and value than the sum of its parts. The strategy generates returns through operational improvement of the platform, multiple arbitrage (acquiring at lower multiples than the eventual exit multiple), and synergy realisation from integration. Buy-and-build is the dominant PE strategy in fragmented mid-market sectors.

Buyer Universe

The buyer universe is the full set of parties who might realistically acquire a particular business. It is usually grouped into trade buyers — competitors, suppliers, customers or adjacent companies that gain strategic value from the acquisition — and financial buyers such as private equity firms, search funds and other investors that buy for a return. Mapping the buyer universe is an early step in a sale: it shapes how the business is positioned, who receives the teaser, and how a competitive process is run to create tension between bidders. Different buyers value different things — a trade buyer may pay for synergies and market position, a financial buyer for cash generation and a platform for further acquisitions — so a wide, well-understood buyer universe helps a seller find the party that values the business most highly.

Business & Finance Glossary: B

Want to see these concepts in action?